K042945 is an FDA 510(k) clearance for the AURA CPAP SYSTEM. Classified as Ventilator, Non-continuous (respirator) (product code BZD), Class II - Special Controls.
Submitted by Aeiomed, Inc. (Stoughton, US). The FDA issued a Cleared decision on March 9, 2005 after a review of 135 days - within the typical 510(k) review window.
This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5905 - the FDA anesthesiology and respiratory device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.
Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.
View all Aeiomed, Inc. devices